Document Detail


Joint WFH-ISTH session: issues in clinical trial design.
MedLine Citation:
PMID:  24762289     Owner:  NLM     Status:  In-Data-Review    
Abstract/OtherAbstract:
Haemophilia therapy is experiencing an unprecedented expansion in the number and novelty of clotting factor concentrates. Every product must be licensed by regulatory authorities, primarily on the basis of its safety and efficacy profiles. The low prevalence of haemophilia, and other inherited bleeding disorders, presents a significant challenge to patient recruitment for preauthorization clinical trials, especially given the low frequency of inhibitory antibodies, the major adverse event related to clotting factor exposure. Other challenges include a lack of harmonization between the major regulatory authorities in certain key areas, the selection of laboratory monitoring methodologies and the difficulty in obtaining high-quality phase IV safety data following authorization. These aspects will be reviewed in this session, which will also highlight the roles played by the World Federation of Hemophilia and International Society on Thrombosis and Haemostasis in the promotion of these discussions.
Authors:
F Peyvandi; A Farrugia; A Iorio; N S Key; A Srivastava
Related Documents :
24292999 - Efficacy of subcutaneous interferon β-1a on mri outcomes in a randomised controlled tr...
8483109 - Functional status and well-being in a placebo-controlled trial of zidovudine in early s...
20733459 - Quality in obstetric care: measuring what matters.
11973949 - Does reflexology impact on cancer patients' quality of life?
2927609 - Cognitive outcome and quality of life one year after subarachnoid haemorrhage.
9174389 - Improvement in the quality of life after i.v. pge1 therapy for intermittent claudication.
11422149 - Comparison of once daily fluticasone propionate aqueous nasal spray with once daily bud...
17597479 - Long-term administration of the low-dose risperidone in schizotaxia subjects.
8388949 - Effects of dexamethasone on chemotactic activity and inflammatory mediators in tracheob...
Publication Detail:
Type:  Journal Article    
Journal Detail:
Title:  Haemophilia : the official journal of the World Federation of Hemophilia     Volume:  20 Suppl 4     ISSN:  1365-2516     ISO Abbreviation:  Haemophilia     Publication Date:  2014 May 
Date Detail:
Created Date:  2014-04-25     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  9442916     Medline TA:  Haemophilia     Country:  England    
Other Details:
Languages:  eng     Pagination:  137-44     Citation Subset:  IM    
Copyright Information:
© 2014 John Wiley & Sons Ltd.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Medical co-morbidities and practice.
Next Document:  Nicotinic ?4 ?2 acetylcholine receptors and cognitive function in Parkinson's disease.